Mesoblast Financials - Benzinga

Mesoblast Ltd

MESONASDAQ

Trade with Public

Trade with Public

$15.12

-0.36-2.33%

가까이에: Sep 25, 5:00 PM EST

$15.21

0.090.6%

시간외: Sep 24, 9:30 AM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

Mesoblast Financials

Mesoblast (MESO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Mesoblast FY EPS $(0.04) Misses $0.01 Estimate, Sales $120.250M Beat $66.000M Estimate

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.01 by 500 percent. This is a 50 percent increase over losses of $(0.09) per share from the same

Benzinga Newsdesk

PRO
Reported Earlier, Mesoblast Reports FY2026 Total Revenue Of $120.3M Up From $17.2M, Net Loss Narrows 44% To $57.5M From $102.1M

Benzinga Newsdesk

PRO
Mesoblast H1 EPS $(0.03) Beats $(0.20) Estimate, Sales $51.342M Miss $72.000M Estimate

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.20) by 84.5 percent. This is a 99.26 percent increase over losses of $(4.20) per share from the same

Benzinga Newsdesk

Earnings Scheduled For February 26, 2026

Benzinga Insights

What's Next: Mesoblast's Earnings Preview

Benzinga Insights

PRO
Mesoblast FY EPS $(0.09) Misses $(0.05) Estimate, Sales $17.20M Up From $5.90M YoY

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 70 percent. This is a 99.05 percent increase over losses of $(8.91) per share from the same

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved